Please login to the form below
Prescription Digital Therapeutics
This page shows the latest Prescription Digital Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Pear Therapeutics is a pioneer of so-called digital therapeutics, having gained the first ever such approval from the FDA in 2017, for its treatment for patients with Substance Use Disorder ... Its Prescription Digital Therapeutics (PDTs) are app-based
Latest news
-
FDA clears Sandoz and Pear’s Opioid Use Disorder app
validated software-based therapeutics, known as Prescription Digital Therapeutics (PDT). ... Richard Francis, CEO, Sandoz. "New digital therapeutics such as reSET-O also have the potential to fundamentally change how patients interact with their
-
Novartis plans digital therapeutics for schizophrenia and MS
Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient outcomes. ... We believe this collaboration further supports the clinical viability of prescription digital therapeutics as an emerging
-
FDA approves first substance use mobile medical application
Corey McCann, Pear’s president and CEO, said: “This is a defining moment for digital therapeutics and for patients with substance use disorder. ... We believe that prescription digital therapeutics hold promise in improving patient outcomes across a
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Events Executive
-
DOE
- Account Manager – Healthcare advertising
-
Salary TBC
- Client Services Director- Flexible Working
-
Negotiable
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Gracell reports impressive data with one-day CAR-T for leukaemia
- Lucid Group increases footprint in UK, Asia Pacific and Middle East with the acquisition of HealthCare21
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Gracell reports impressive data with one-day CAR-T for leukaemia
- Zenopa delivers Communiqué prizes to winners
- Detecting Alzheimer’s ahead of a cure
- When it’s OK to not be OK: Bedrock breaks down mental health stigma
- Roche wins FDA breakthrough for Gazyva in lupus nephritis
- Programmatic methodology and why you should be using it
- Biogen loses another pipeline drug to toxicity concerns
PMHub
GCI Health
GCI Health is an integrated communications agency designed for and inspired by the ever-changing face of healthcare. In London, we...
Latest intelligence
- Detecting Alzheimer’s ahead of a cure
- A focus on promising new research...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
- Can you survive without the blue dot?
- Or has the digital world has replaced our brain...
Quick links
Infographics
